Uses of LitorAPC 10

LitorAPC 10 is the preferred drug class indicated for the treatment of lowering total cholesterol, LDL-cholesterol, apolipoprotein B and triglycerides and to increase HDL-cholesterol. The following article will help you better understand the uses of LitorAPC 10.

1.1. What is LitorAPC 10? LitorAPC 10 is a cardiovascular medicine containing the main ingredient Atorvastatin in the form of Atorvastatin calcium trihydrate 10mg and is available in the form of film coated tablets. Packing Box with 1 blister, box of 3 blisters, box of 10 blisters, each blister contains 10 tablets of LitorAPC 10 film coated.
1.2. What is LitorAPC 10 used for? Atorvastatin is indicated for the reduction of Total Cholesterol, LDL-Cholesterol and Spolipoprotein B or triglycerides and for the increase of HDL-Cholesterol in patients with primary hypercholesterolemia. Patients with beta lipoprotein disorders in the blood that do not respond adequately to diet. Atorvastatin is also indicated for the reduction of total cholesterol and LDL-cholesterol in patients with homozygous familial hypercholesterolemia on diet.

2.1. How to use LitorAPC 10 The routes of administration depend on the form of the drug, such as: drugs for oral administration, or drugs for injection, drugs for external use or drugs for suppositories. It is best for patients to carefully read the instructions on how to use LitorAPC 10 listed on the drug leaflet. LitorAPC 10 is a tablet that should be taken orally and taken immediately after eating.
LitorAPC 10 can be taken at any time of the day, regardless of the meal.
2.2. Dosage of LitorAPC 10 Hypercholesterolemia (heterozygous familial, or non-familial) and mixed dyslipidemia: The recommended initial dose is 10 to 20 mg once daily. . Patients who need to reduce their LDL cholesterol by more than 45% can start with a dose of 40mg once a day. The therapeutic dose range of the drug is 10 to 80 mg once daily. After initiation of therapy or after increasing the dose of LitorAPC 10 with the main ingredient Atorvastatin, blood lipids should be assessed within 2 to 4 weeks and the dose adjusted accordingly. Homozygous familial hypercholesterolemia: 10 to 80 mg daily. Should be combined with other lipid-lowering measures. Combination therapy: LitorAPC 10 has the main ingredient atorvastatin which can be used for treatment in combination with resins to increase the therapeutic effect. Dosage in patients with renal impairment: No dose adjustment is required. Usually medications can be taken within 1 to 2 hours of what is indicated on the prescription. Unless there is a strict rule about the time of use, the patient can take the medicine a few hours after forgetting it. However, if the time is too close to the time when the next dose should be taken, do not take the supplement, which can be dangerous for the body. It is necessary to strictly follow the instructions given by the specialist.
In addition, prescription drugs require a prescription from a specialist or pharmacist, and non-prescription drugs require instructions for use from the manufacturer. Patients should carefully read and follow the exact dose indicated on the prescription or drug leaflet. When using an overdose of LitorAPC 10, you need to stop taking it and immediately notify a specialist or pharmacist when you feel unusual symptoms.
Unusual manifestations when taking an overdose of LitorAPC 10 should notify the doctor or medical person in charge. In case of an overdose of LitorAPC 10, there are symptoms that require emergency: Call 911 immediately for guidance and help. Family members should bring medical records, all prescriptions, medicine bottles that have been and are being used so that doctors can quickly diagnose and treat

3.1. Contraindications Hypersensitivity to HMG-CoA reductase inhibitors Patients with advanced liver disease or persistent elevations of serum transaminases of unknown cause. 3.2. Drug interactions Patients need to remember that LitorAPC 10 drug interactions with other drugs are often quite complicated due to the influence of many ingredients in the drug. Studies or recommendations often only list the most common interactions with use. Therefore, do not arbitrarily apply information about LitorAPC 10 drug interactions if you are not a researcher, doctor or medical officer.
Anticoagulants, Indandione in combination with Atorvastatin will increase bleeding time or prothrombin time. Prothrombin time must be monitored in patients receiving concomitantly with anticoagulants such as Cyclosporine, Erythromycin, Gemfibrozil, immunosuppressants, Niacin: concomitant use increases the risk of myopathy. Digoxin: Co-administration with Atorvastatin causes a slight increase in Digoxin serum concentrations. Patients should consider co-administration of LitorAPC 10 with alcohol, tobacco, and alcoholic or fermented beverages. Factors that can change the composition of the drug. See details in the leaflet or consult your doctor or pharmacist for more details. Pregnant women should consider and consult their doctor or pharmacist before taking the medicine. Even tested drugs still have risks when used. In addition, breastfeeding women also need to carefully weigh the benefits and risks for mother and baby. Do not arbitrarily use the drug without carefully reading the instructions for use and instructions of the doctor to protect the mother and baby.

Before treatment with Atorvastatin, care should be taken to exclude secondary causes of dyslipidemia and measure lipid indices, which should be measured periodically, at intervals of not less than 4 weeks. During treatment with HMG-CoA reductase inhibitors, if creatine kinase is elevated, myositis develops, or serum liver enzyme levels rise to 3 times the upper limit of normal, the dose should be reduced or treatment discontinued. Use with caution in patients with liver dysfunction, patients with heavy alcohol consumption. Patients need to have a reasonable diet before treatment with the drug, should maintain this diet throughout the course of treatment with the drug.

Atorvastatin is generally well tolerated, side effects are usually mild and transient. Possible side effects when taking the drug such as: Constipation, flatulence, indigestion, abdominal pain, nausea, vomiting, headache, dizziness.
Usually the side effects or unwanted effects (Adverse Drug Reaction (ADR) unwanted effects will go away when the drug is stopped. If there are rare side effects that are not mentioned in the leaflet. Inform your doctor or medical person immediately if you suspect any side effects of LitorAPC 10

Preserve the medicine in the family medicine cabinet, avoid the blister pack being torn and exposed to the air for too long without using, changing the quality of the medicine.
Keep out of reach of children. Store at a temperature not exceeding 30 degrees, in a cool, dry place. Avoid direct light.
LitorAPC 10 is a prescription drug, so it should not be used without a prescription from a specialist.
Carefully read the instructions for storage information on the drug packaging and the instruction sheet for use of the drug LitorAPC 10. Check the expiry date of the medicine. When not in use, the drug should be collected and disposed of according to the instructions of the manufacturer or the person in charge of medicine. Conventional drugs are stored at room temperature, avoiding direct sunlight or high temperature, which can cause metabolism of the ingredients in the drug.